Depletion of polyfunctional CD26<sup>high</sup>CD8<sup>+</sup> T cells repertoire in chronic lymphocytic leukemia.

Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics and consent to participateThis study was reviewed and approved by the Health Research Ethics Board of Alberta, Cancer Committee (HREBA#CC-17-0307). All participants provided informed written consent to participate in this study. Moreover, animal studies were approved by the animal ethics board at the University of Alberta with the protocol number AUP0001021. Consent for publicationAll authors consented to publish the study. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding This study was supported by the Canadian Institute for Health Research (CIHR) through a Foundation Grant and an operating grant from the Cancer Research Society (both to SE). Nevertheless, the funding bodies had no role in the design of the study, data collection, analysis and publication."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025